🇺🇸 FDA
Patent

US 12098116

Crystalline prostacyclin (IP) receptor agonist and uses thereof

granted A61PA61P9/12

Quick answer

US patent 12098116 (Crystalline prostacyclin (IP) receptor agonist and uses thereof) held by United Therapeutics Corporation expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P9/12